Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile
Rami Z. Morsi, MD

@drramimorsi

Vascular neurology fellow @UChicagoMed via @NeuroUCMC 🧠 | Former intern @Endeavorhlth | @AUB_Lebanon alumnus | RT/Likes are not advice/endorsements. 🇦🇺🇱🇧

ID: 815696390017974276

linkhttps://www.linkedin.com/in/rami-z-morsi calendar_today01-01-2017 23:09:09

1,1K Tweet

1,1K Takipçi

698 Takip Edilen

Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

Excited to be joining Curvia to help students develop the skills they need to become experienced researchers. Looking forward to working with the team, and especially Amin Nassar, MD for such a great initiative!

Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

Every 10 mg/dL ⬇️ in LDL for patients with ICAD stroke has 9% ⬇️ rates of recurrent stroke or MI. this theoretical framework suggests that PCSK9i can help achieve this. We need PCSK-9i trials in ICAD Jim Siegler (@jimsieglermd.bsky.social now) Tareq Kass-Hout Malik Ghannam Seemant Chaturvedi neurology.org/doi/10.1212/WN…

AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Estimated Theoretical Benefit of Aggressive LDL Lowering in Patients With Symptomatic Intracranial Atherosclerosis | Neurology neurology.org/doi/10.1212/WN…

Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

🧠 New Stroke AHA/ASA commentary out on the ALLY pilot trial! Exploring intraarterial tenecteplase after mechanical thrombectomy - promising results for stroke outcomes. Read more: ahajournals.org/do/10.1161/blo… #StrokeMedicine #MedTwitter #Neurology

Andrea J. Darzi MD, MPH, PhD (@andreadarzi) 's Twitter Profile Photo

Just out: Our SR (44 studies, ~10K IMEs) shows low CoE that higher rates of symptom exaggeration in studies with ≥40% women (47%) vs <40% (31%). A multimodal approach including validated tests of performance measures is needed for IME evals. journals.plos.org/plosone/articl…

Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

Missed being at SNIS Info this year, but still got hands-on with the Johnson & Johnson Neurovascular flow model, right here in one of the angio suites. Bringing a piece of SNIS to me! #SNIS2025

Missed being at <a href="/SNISinfo/">SNIS Info</a> this year, but still got hands-on with the <a href="/JNJNews/">Johnson & Johnson</a> Neurovascular flow model, right here in one of the angio suites. Bringing a piece of SNIS to me! #SNIS2025
Galaxy Therapeutics (@galaxythera) 's Twitter Profile Photo

🌍 SEAL IT IDE Trial update 🌍 Ruptured case successfully treated by Dr. Kass-Hout @ University of Chicago ➡️ 238 patients enrolled! Thank you to Dr. Kass-Hout & team for their outstanding work! #SEALIT #BrainAneurysm #Neurointervention

🌍 SEAL IT IDE Trial update 🌍
Ruptured case successfully treated by Dr. Kass-Hout @ University of Chicago ➡️ 238 patients enrolled!
Thank you to Dr. Kass-Hout &amp; team for their outstanding work!
#SEALIT #BrainAneurysm #Neurointervention
Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

Would you treat a low-grade AVM (~10.6×7.8mm) without high-risk features in an octogenarian? If yes, how (embolization, radiosurgery, observation, surgery)? When would you intervene? Curious to hear your approaches and rationale!

Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

This was a phenomenal course for fellows. I genuinely learned a lot, a very unique experience. Highly recommend for next year! Lucky to train with you, Tareq Kass-Hout, and thanks to Sonam Thind for organizing this extraordinary meeting.